The CD3D Knockout HAP1 Polyclonal Cells product comprises a CRISPR/Cas9-edited polyclonal knockout cell population with targeted disruption of the CD3D gene. This heterogeneous loss-of-function model is optimized for investigating CD3??-dependent signaling pathways and protein interactions in a defined genetic background. The polyclonal format reduces clonal artifacts and is ideal for robust functional screening, allowing researchers to dissect the role of the CD3?? subunit in T-cell receptor/CD3 complex-mediated signal transduction and immune cell function.
The parental HAP1 cell line is a near-haploid human chronic myeloid leukemia-derived line. Its haploid karyotype permits efficient generation of complete loss-of-function alleles via CRISPR/Cas9, making it a favored platform for genetic screens and saturation mutagenesis. Although non-lymphoid, HAP1 cells can be engineered to express exogenous TCR/CD3 components, enabling reconstitution of lymphoid signaling modules in a simplified, genetically tractable system. This background eliminates endogenous CD3 expression, providing a clean null background for functional studies.
CD3D encodes CD3??, an essential subunit of the CD3 coreceptor that assembles with TCR??/?? and CD247 to form the antigen recognition complex. Upon TCR engagement by peptide?CMHC, ITAMs in CD3?? are phosphorylated by Src kinases LCK and FYN, recruiting ZAP70. ZAP70 then activates LAT and SLP-76, triggering MAPK (ERK, JNK), NF-??B, and NFAT pathways that drive T-cell proliferation, differentiation, and cytokine production (IL-2, IFNG). CD3D is thus indispensable for proximal TCR signaling, and its deficiency causes severe combined immunodeficiency and immunodeficiency 19, underscoring its central role in T-cell development and activation.
In HAP1 cells, which lack endogenous TCR and CD3, the CD3D knockout population offers a pristine background for reconstitution studies. By expressing defined TCR components, researchers can dissect the specific contribution of CD3?? to receptor assembly, surface trafficking, and signal initiation without confounding endogenous signals. The haploid genetics ensure direct genotype?Cphenotype links, facilitating interpretation of CRISPR screens and genetic interaction studies. This model is particularly suited for high-throughput drug screens to identify modulators of TCR-proximal signaling or synthetic lethal interactions involving CD3D loss.
Key applications include systematic analysis of TCR/CD3 signaling modules, validation of immunotherapy targets, and mechanistic studies of primary immunodeficiencies. The polyclonal cells support co-immunoprecipitation mapping of CD3?? interaction partners (e.g., CD3E, CD3G, LCK), phospho-signaling analysis (pZAP70, pLAT), and functional reconstitution with modified TCRs. They are also amenable to drug sensitivity profiling with kinase inhibitors targeting Src kinases, ZAP70, or MAPK nodes. For additional information or custom requests, please contact Ascent Research.
